Critical Care

official impact factor 4.60

This article is part of the supplement: Severe sepsis and drotrecogin alfa (activated)

Highly Access Review

Diagnosis and treatment of severe sepsis

Yann-Erick Claessens and Jean-François Dhainaut*

Critical Care 2007, 11(Suppl 5):S2 doi:10.1186/cc6153

No comments have yet been made on this article.

Post a comment